eLetters is an online forum for ongoing peer review. To submit an eLetter please go to the article you wish to respond to and click on the link that reads "eLetters: Submit a Response." Submission of eLetters are open to all health care professionals and experts in related fields.

eLetters to:

ARTICLES:
Brenda Eskenazi, Amy R. Marks, Asa Bradman, Laura Fenster, Caroline Johnson, Dana B. Barr, and Nicholas P. Jewell
In Utero Exposure to Dichlorodiphenyltrichloroethane (DDT) and Dichlorodiphenyldichloroethylene (DDE) and Neurodevelopment Among Young Mexican American Children
Pediatrics 2006; 118: 233-241 [Abstract] [Full text] [PDF]
*eLetters: Submit a response to this article

eLetters published:

[Read eLetters] DDT and neurodevelopment: results inconclusive to effect policy change
Ameena E Goga   (7 August 2006)
[Read eLetters] Dichlorodiphenyltrichloroethane. Implications of Eskenazi et al study to malaria control in Africa
BARNABAS N KAHIIRA   (15 August 2006)
[Read eLetters] Re: Dichlorodiphenyltrichloroethane. Implications of Eskenazi et al study to malaria control in Afri
Brenda Eskenazi, Amy R. Marks, Asa Bradman, Caroline Johnson, Nicholas P. Jewell   (24 August 2006)
[Read eLetters] Re: DDT and neurodevelopment: results inconclusive to effect policy change
Brenda Eskenazi, Amy R. Marks, Asa Bradman, Caroline Johnson, and Nicholas P. Jewell   (22 September 2006)

DDT and neurodevelopment: results inconclusive to effect policy change 7 August 2006
 Next eLetters Top
Ameena E Goga,
Child Health Specialist
CAPRISA*

Send letter to journal:
Re: DDT and neurodevelopment: results inconclusive to effect policy change

gogaa1{at}ukzn.ac.za Ameena E Goga

Sir – The paper by Eskenazi and colleagues has raised concerns about the effect of in utero exposure to DDT and DDE on neurodevelopment in Mexican American children. The findings are of interest to environmentalists, policy-makers, child-health specialists and public- health specialists. However, the paper’s conclusion that the study has ‘important implications for countries that are reconsidering or continuing the use of DDT for malaria control..’, assumes that the results of this study are conclusive, and should thus affect policy. I would like to raise the following concerns about the study to illustrate that more data are needed: (i) to provide conclusive evidence that in utero exposure to DDT and (to a lesser extent DDE) may be associated negatively with neurodevelopment and (ii) before policy-changes regarding DDT-use in resource-limited countries where controlled spraying of DDT best eradicates the malaria vector, can be recommended.

Sample: Although the data were gathered from participants in a longitudinal birth cohort study our sense is that the 6, 12 and 24 months data on development should be interpreted as assessments, at three time points, on groups that slightly differed in their characteristics i.e. the assessments do not represent developmental trajectories of the children assessed at 6 months. This assumption is supported by the fact that data are presented for 360 mothers (not 330). It would be important to see the relationship between DDT and neurodevelopment in exactly the same group of children at 6, 12 and 24 months. If the sample of children at 6, 12 and 24 months differ, one wonders whether the reasons for either missed visits or missed assessments at 12 and 24 months were in any way related to exposure or outcome.

Loss to follow-up/non-inclusion in analysis: Although the original cohort was 601 women, blood levels of DDT were obtained for only 526 women, and the association between DDT/DDE levels and BSID scores were only ascertained in 330, 327 and 309 children (6, 12 and 24 months respectively) i.e. in a little more than half the original sample. It is not clear how / whether the children / mothers excluded from the final analysis differed from children/mothers included in the analysis. Were the children included in the analysis at higher risk of obtaining lower scores, for reasons other than DDT exposure? Did mothers who were excluded have lower DDT/DDE levels, or would their infants have had poorer neurodevelopmental outcomes than those included in the sample due to reasons other than DDT?

Measuring exposure: Exposure was agricultural – It is not clear what levels of agricultural exposure had led to the high blood DDT/DDE levels, and whether controlled indoor household residual spraying of DDT for malaria control (using a low dose - approximately 1-2g/m2) would produce the same exposure level. Furthermore, mother’s blood level was used as a proxy for infants exposure. Though this may be correct [1] , postnatal exposure to DDT/DDE was not known, and thus not accounted for.

Measuring and interpreting outcome: The Bayley scales of infant development (BSID) were used to measure mental and psychomotor development, using the US population as a standard. Several issues are of concern here: (i) The BSID may be used to describe the current developmental functioning of infants However, their stability (repeated measures using the same test) and predictive power are not high [2]. The article, by stating that the study has implications for malaria control, suggests that the decrease in BSID scores are clinically significant. However, the original version of the BSID scale for infants and toddlers up to 24 mo of age has failed to show construct and predictive validity. Although BSIDII incorporated a new standardization of the mental scale it has shed no new light on its construct validity up to the ages of 18–24 months [2,3,4]. Studies have shown that the median correlation between the mental development scores obtained at some point between 7 and 12 months and an IQ obtained sometime between 5 to 7 years of age was about 0.20 [5,6].This means that the finding that a 10-fold increase in p,p’-DDT, o,p’-DDT, and p,p’-DDE levels were significantly associated with decreases in 12- and 24-month MDI scores are likely to not have any bearing / significance for later development and IQ. Furthermore, although the analysis controlled for psychometricians, it would have been useful to have conducted and reported on a preliminary pilot to determine the correlation coefficients for intra and inter- observer BSID scores.

Measuring confounders and other variables: Postnatal exposure to other neurotoxicants, and other confounders such as nutritional status (infants weight for age / weight for height at each assessment), diet, type of delivery, length of second stage of labour, birth trauma were not measured and controlled for. Did women with higher DDT exposure also have other such characteristics that increased their infant’s risk of getting low scores on the BSID?. Furthermore although the study measured depressive symptomotology using a standardized scale it is not clear how relevant and reliable this scale was to identify depression in this newly immigrant population, and how this may have affected the relationship between exposure and outcome.

Statistical analysis: The statistical analysis treated DDT/DDE levels as a continuous variable – possibly because the researchers believe that any exposure to DDT leads to adverse outcome. It would be interesting to also see the analysis conducted using DDT/DDE levels as a dichotomous variable (equal to or above the geometric mean and below the geometric mean) to determine whether the scores are significantly different. Furthermore, the analysis in this study lumped all DDT exposures and outcomes, including the group with no known exposure into one group. Future research on DDT exposure and developmental outcome should, for public health purposes, look at exposure and outcome for three different groups of mother-infant pairs: (i) known agricultural exposure (ii) known exposure only through controlled indoor household residual spraying (iii) no known exposure to DDT to determine whether outcome differs significantly between groups.

Other issues of concern: The authors report on standardized scores, which, in this population, are lower than the expected mean standardized score for the US population. The authors also do not state whether the BSID were modified to make them more relevant to the newly immigrant population. It is not clear what each mother was told about her child’s neurodevelopment, and future, in relation to the scores obtained. Caution is usually warranted in using the BSID for populations that differ from the standardization sample and some examiners who use the BSID for research purposes report raw scores, rather than relying on U.S. norms [7] Furthermore, the assumption after reading the article is that BSID II was used. BSIDII requires that examiners have training and experience in administering and interpreting standardized assessments with infants as test administration and interpretation is more complex than with other standardized assessments because the examiner alters the sequence of items in response to the infant’s behavior and performance [7]. Typically examiners have training at the master’s or doctoral level and supervised experience, in accordance with guidelines from the American Psychological Association. The paper does not state the level of skill of the pschometricians.

Looking forward: As stated by the authors I agree that (i) the beneficial role of breastfeeding, in the context of DDT use should be explored further, particularly as breastfeeding is usually a norm in areas of high malaria endemnicity, and in areas where DDT is currently being used for malaria control (ii) the cohort assessed should be followed up and developmental trajectories developed for each child to ascertain the clinical significance of the results.

References

1. Waliszewski SM, Aguirre AA, Silva CS, Siliceo J. Organochlorine Pesticide Levels in Maternal Adipose Tissue, Maternal Blood Serum, Umbilical Blood Serum, and Milk from Inhabitants of Veracruz, Mexico. Arch. Environ. Contam. Toxico. 2001; 40: 32–438.

2. Pollitt E. Statistical and psychobiological significance in developmental research. American Journal of Clinical Nutrition. September 2001; 74:3, 281-282, .

3. McCall RB, Mash CW. Long-chain polyunsaturated fatty acids and the measurement and prediction of intelligence (IQ). In: Dobbing J, ed. Developing brain and behavior. San Diego: Academic Press, 1997:295–329.

4. Pollitt E, Triana N. Stability, predictive validity, and sensitivity of mental and motor development scales and pre-school cognitive tests among low-income children in developing countries. Food Nutr Bull. 1999;20:45–52.

5. McCall RB. A conceptual approach to early mental development. In: Lewis M, ed. Origins of intelligence. 2nd ed. New York: Plenum Press, 1983:255-301.

6. McCall RB. The development of intellectual functioning in infancy and the prediction of later IQ. In: Osofsky JD, ed. Handbook of infant development. New York: Wiley, 1979:704-41.

7. Black MM, Matula K. Essentials of Bayley scales of infant development. II. Assessment. New York, NY: Wiley, 2000.

*Ameena Goga is supported by CAPRISA which forms part of the Comprehensive International Program of Research on AIDS (CIPRA) funded by the National Institute of Allergy and infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) (grant# 1 U19 AI51794), and the Columbia University- Southern African Fogarty AIDS International Training and Research Programme (AITRP) funded by the Fogarty International Center, National Institutes of Health (grant # D43TW00231.

Conflict of Interest:

None declared

Dichlorodiphenyltrichloroethane. Implications of Eskenazi et al study to malaria control in Africa 15 August 2006
Previous eLetters Next eLetters Top
BARNABAS N KAHIIRA,
Public Health
Braun School of Public Health

Send letter to journal:
Re: Dichlorodiphenyltrichloroethane. Implications of Eskenazi et al study to malaria control in Africa

nkbarna{at}yahoo.com BARNABAS N KAHIIRA

Reference is made to the article on the effects of DDT and it degraded form DDE on neurodevelopment of young Mexican American children by Eskenazi et al1 that recently appeared in Pediatrics. I would like to commend the authors for undertaking this study; the first of its kind to prospectively assess the direct effects of DDT on human subjects. That said, I have several methodological and statistical considerations to highlight that I think may limit our interpretation of their findings.

To begin with, though the researchers measured several prenatal and post natal exposures, I am worried why they did not prospectively measure the nutritional status of these infants and children particularly their hemoglobin status. Studies have demonstrated that anemic infants and young children are more likely to be mentally retarded than those who are non anemic2 and that micronutrient supplements containing iron can improve children's mental development.3 The authors of this study, without assessing variables associated with iron deficiency and supplementation of these young Mexican children leave us to suspect that the observed relationship though minor may be explained easily by a third variable.

Secondly, it must be noted that although they measured and included maternal depressive symptoms in the analytical models, only the models where this important variable is not included in the analysis show significant results. Indeed about 52% of the participating women screened positive for depression in their study. Motor and early development of children is known to depend on their mother's mental health status such as depression,4-5 one would have expected the researchers to keep this variable whether significant or not in the final models so as to make meaningful inferences. The authors do not tell us why maternal depression is presented in models with no significant results but not in the models showing significant results.

Thirdly, Eskenazi et al performed several statistical comparisons in their study. However, they did not adjust for this in their statistical methods. Surely they present several p-values and it turns out that only two are significant at á=5%. The third p-value they indicate to be significant is only so at p<0.10! The effect of multiple comparisons on study results and how these can be remedied has been described by others.6 -7 We can't rule out the risk that these p-values might be significant just by chance alone.

Last but not least, even if we were to take their findings as being right, we need to ask their relevance to the use of DDT in malaria control now being advocated for around the world. This is particularly important in Africa; as the World Health Organisation (WHO) estimates that 90% of around one million malaria deaths worldwide take place in the impoverished continent.8 Mexico where the study participants migrated from; DDT use was, until its recent ban, carried out largely outdoors permitting widespread environmental contamination and bioaccumulation in animal tissues. This very much contrasts the controlled use of DDT through indoor residual spray (IRS) being sought today. With controlled use of DDT through IRS, it's entry into the food chain and ecosystem can be kept at very minimal levels. Again studies have shown that DDT easily degrades under relatively higher temperatures, as exists in tropical Africa, to its breakdown product DDE.9 With their study showing no association between maternal DDE levels with children's neurodevelopment, I would think that this further dilutes the relevance of the effects of DDT observed in this study even if we were to take the findings seriously.

With all these inconclusive results and graphical presentations showing ideally no trend, I would like to ask the authors what their recommendation would be, to a country in Sub-Saharan Africa such as Uganda which estimates to lose at least 320 lives to malaria daily (Ugandan press) bearing in mind the ever-growing resistance to antimalarial drugs and lack of cost-effective alternatives to DDT.

Thank you

Barnabas Natamba Kahiira Braun School of Public Health and Community Medicine Hebrew University of Jerusalem

REFERENCES

1. Eskenazi B, Marks AR, Bradman A, et al. In Utero Exposure to Dichlorodiphenyltrichloroethane and Dichlorodiphenyldichloroethylene and Neurodevelopment Among Young Mexican American Children Pediatrics 2006; 118; 233-241

2. Krieger HE, Claussen AH, Scott KG Early childhood anemia and mild or moderate mental retardation American Journal of Clinical Nutrition, 1999; 69:115-119.

3. Saco-Pollitt C, Pollitt E, Harahap H, Jahari AB, Husaini MA. Effects of an energy and micronutrient supplement on iron deficiency anemia, physical activity and motor and mental development in undernourished children in Indonesia. European journal of Clinical Nutrition 2000; 54: S114-S119

4. Gross D, Conrad B, Fogg L, Willis L, Garvey C. A longitudinal study of maternal depression and preschool children's mental health. Nurs Res. 1995; 44: 96-101.

5. Murray L, Fiori-Cowley A, Hooper R, Cooper P. The Impact of Postnatal Depression and Associated Adversity on Early Mother-Infant Interactions and Later Infant Outcome. Child Development1996; 67: 2512- 2526

6. Bland JM, Altman DG Multiple significance tests: the Bonferroni method. BMJ 1995; 310:170

7. Voss S and George S Multiple significance tests BMJ 1995 310: 1073.

8. Samuel T, and Pillai MK The effect of temperature and solar radiations on volatilisation, mineralisation and degradation of [14C]-DDT in soil. Environ Pollut. 1989; 57: 63-77

9. WHO (World Health Organization). Malaria in Africa. Roll Back Malaria Initiative. Available on http://www.who.int/mediacentre/factsheets/fs094/en/ Accessed on July 14, 2006

Conflict of Interest:

None declared

Re: Dichlorodiphenyltrichloroethane. Implications of Eskenazi et al study to malaria control in Afri 24 August 2006
Previous eLetters Next eLetters Top
Brenda Eskenazi,
Director, Center or Children's Environmental Health Research
School of Public Health, UC Berkeley,
Amy R. Marks, Asa Bradman, Caroline Johnson, Nicholas P. Jewell

Send letter to journal:
Re: Re: Dichlorodiphenyltrichloroethane. Implications of Eskenazi et al study to malaria control in Afri

eskenazi{at}berkeley.edu Brenda Eskenazi, et al.

We thank Dr. Kahiira for his commendations and comments. We try to address each of his concerns below:

1. Concern that we did not control for nutritional status of children, in particular hemoglobin status: Although a child’s hemoglobin status may be related to neurodevelopment, there is no evidence in the literature that iron deficiency is related to DDT exposure, and therefore it is not likely to be a true confounder. Nevertheless, we re-ran our models controlling for iron deficiency based on hematocrit values recorded in the medical record near the time of the assessments. We found that iron deficiency was not associated directly with DDT or Bayley scores and did not change the observed associations with DDT/E.

2. Concern that we did not control for maternal depression in some models: Based on the literature, we considered maternal depressive symptoms as a possible confounder in all analyses. As described in the paper, a variable was included in the multivariate models if it was related to the outcome at p<0.10 or changed the coefficient for DDT or DDE by at least 10%.[1] The only Bayley model in which there was even a weak association with maternal depression was with psychomotor development index (PDI) at 24 months. Thus, the variable for maternal depressive symptoms was not included in the mental developmental index (MDI) models because it did not fulfill these criteria.

3. Concern that we did not adjust for multiple comparisons: We first note that Dr. Kahiira misread our findings in that we had 7 (not 2) negative associations at p<0.05: o,p’-DDT with MDI at 12 and 24 months (p<0.01); p,p’-DDT with MDI at 12 and 24 months (p<0.05); p,p’-DDT with PDI at 6 and 12 months (p<0.05); and p,p’-DDE with PDI at 6 months (p<0.05)(Table 3 of manuscript[1]).

While Dr. Kahiira raises an important issue with regard to adjustment for multiple comparisons, this is not as serious a concern as it might appear at first glance. Because of the interrelationships amongst the exposures and amongst the outcomes, the 18 comparisons shown in Table 3[1] are not independent. The serum levels of the three analytes (p,p-DDT, o,p, -DDT, and p,p-DDE) were highly correlated (pairwise r=0.8 to 0.9; p<0.001 [1]); we reported their findings separately because their high degree of collinearity prevented us from modeling them simultaneously. In addition, MDI and PDI were moderately correlated at each of the three time points (r=0.3 to 0.6; p<0.001) and, although not as strong, across ages (r=0.1 to 0.3; p<0.04). Thus, a Bonferroni correction might be considered unduly conservative. [2] Nevertheless, even employing a Bonferroni adjustment for six independent comparisons (allowing for independence of outcomes but not of exposures), our findings for MDI and o,p,-DDT at 12 (p=0.004) and 24 months (p=0.007) would still be considered “statistically significant” at á=0.05.

Further, the evaluation of the relationship of DDT and neurodevelopment should not focus solely on the issue of statistical significance. While perhaps not clinically relevant on an individual level, a few points on the Bayley MDI scale may be relevant at a population level. That is, a downward shift in the distribution of a population’s neurodevelopmental scores could result in a larger fraction of children falling in the tail of the distribution with clinically significant developmental problems.

4. Concern about the relevance of our findings to current use of DDT for malaria control: A recent study of DDT levels in breastmilk in South African women living in regions where DDT has been used for IRS[3] suggest that exposures are at least as high as those in our study (adjusting for the ratio of DDT in breastmilk and serum[4]), which were associated with decrements in child neurodevelopment. However, it is not possible to determine the specific sources and pathways of DDT exposure in these populations, which may be due to environmental contamination from agricultural use, residues in the food supply, broadcast applications for public health purposes, or indoor uses on nets or interior residual spraying (IRS) for malaria control. To date, surprisingly little quantitative data have been published about the specific contribution of IRS to human DDT exposure.

Dr. Kahiira reports that DDT readily breaks down to DDE in the high temperatures of tropical countries, and therefore, he concludes, there is less concern about DDT use given that our findings with DDE were weaker. However, IRS is recommended every six to twelve months[5] and repeated DDT spraying may lead to continuous exposure. Given its long half-life in humans (~6 years[6]), DDT might accumulate in the human body with regular use even if it breaks down to a less biologically active product in the environment. Again, empirical data on the specific contribution of IRS to human DDT exposures is needed.

The cost of malaria in terms of human suffering is undeniably high. We are not in a position to endorse a particular policy regarding the use of DDT as an efficacious method for controlling this horrific disease, but rather we offer our research to help inform those who are making such policy decisions. Clearly, our research, the first to study the association between neurodevelopment and DDT, needs to be confirmed in other populations, and the children in our study should be followed to determine if our findings persist as the children enter the school years. Exposure in human populations should be monitored and potential health consequences should be studied to inform policy.

Thank you.

REFERENCES

1. Eskenazi B, Marks AR, Bradman A, et al. In utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethylene (DDE) and neurodevelopment among young Mexican American children. Pediatrics 2006;118(1):233-41.

2. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. Bmj 1995;310(6973):170.

3. Bouwman H, Sereda B, Meinhardt HM. Simultaneous presence of DDT and pyrethroid residues in human breast milk from a malaria endemic area in South Africa. Environ Pollut 2006.

4. Waliszewski SM, Aguirre AA, Infanzon RM, Siliceo J. Persistent organochlorine pesticide levels in maternal blood serum, colostrum, and mature milk. Bull Environ Contam Toxicol 2002;68(3):324-31.

5. World Health Organization. Frequently asked questions on DDT use for vector control. Geneva: World Health Organization; 2005.

6. Wolff MS. Half-lives of organochlorines (OCs) in humans. Arch Environ Contam Toxicol 1999;36(4):504.

Conflict of Interest:

None declared

Re: DDT and neurodevelopment: results inconclusive to effect policy change 22 September 2006
Previous eLetters  Top
Brenda Eskenazi,
Director, Center for Children's Environmental Health Research
School of Public Health, University of California, Berkeley,
Amy R. Marks, Asa Bradman, Caroline Johnson, and Nicholas P. Jewell

Send letter to journal:
Re: Re: DDT and neurodevelopment: results inconclusive to effect policy change

eskenazi{at}berkeley.edu Brenda Eskenazi, et al.

We thank Ms

Dear Editor:

 

We thank Dr. Goga for her thoughtful feedback. First, we agree that no single epidemiologic investigation should be considered conclusive and that our study results clearly need to be replicated in other populations, but we also believe that all data from well-conducted studies, conclusive or not, should be considered for policy decisions. We try to address each of her specific concerns below:

 

1. Sample: There were 281 children with DDT/E measurements and Bayley assessments at all three ages. When multivariate analyses were limited to these children and compared to those for the full sample available at each time, the patterns of associations were similar and, in most cases, the coefficients and p-values were stronger, despite the smaller sample sizes. Also, we conducted longitudinal analyses, as stated in the text [1], and the results were similar.

 

2. Loss to follow-up/non-inclusion in analysis: While 601 women were enrolled in the study [1], 20 miscarried, 5 neonates/fetuses died, and 43 dropped (mostly due to relocation) before delivery, leaving 531 followed past delivery and 476 followed to 6 months. We performed Bayley assessments at least once on 459 children, or on 86% of infants alive and in the study following delivery. Blood levels of organochlorines were measured for 426 women (rather than 526 as stated by Dr. Goga), yielding an overlap with Bayley assessments of 364 children; those not analyzed were due to lack of a stored serum sample of adequate volume. As suggested, to investigate potential bias introduced by non-inclusion, we made the following comparisons:

a. We compared the baseline demographic characteristics of those in the original cohort and the sample included in the paper (i.e., those who had both DDT/E levels and Bayley scores) and found that women not included were more likely to smoke and were less likely to be married or living as married. Controlling for these factors did not alter our results.

b. We compared exposure levels in those who had a Bayley assessment performed at all time points and those who did not and found no significant differences in DDT or DDE levels.

c. We compared the Bayley scores of those who had DDT/E levels and those who did not and found that Bayley scores did not differ at 24-months where we observed the strongest associations. However, children without DDT/E measurements had lower 12-month MDI.

 

We further note that selection bias arising from non-inclusion solely on the basis of high or low Bayley scores would tend to bias the association with DDT/E exposure towards the null. Selection bias on the basis of exposure is irrelevant since all regression analyses already condition on the observed values of the explanatory variables.

 

3. Measuring exposure: It is not possible to know the proportion of the DDT/E levels observed in this population due to agricultural exposure versus anti-malaria efforts. Women in our study who were born in coastal Mexico had significantly higher levels of DDT and DDE than those who did not, and levels increased with the number of years spent outside of the U.S. [2]. 

 

In northern and central Mexico, agricultural DDT use declined in mid-1970s in response to U.S. import standards for OC residues [3], and in 1990 the Cicoplafest commission seriously restricted DDT use, which was then banned nationwide in 1997 for purposes other than public health use inside dwellings. DDT use for malaria control continued in coastal areas until 2000.

 

To date, very little information has been published on exposure resulting from IRS with DDT. Background levels in individuals living in African nations with historical or current DDT use appear to be at least as high [4,5] as those observed in our population (please see our response to Kahiira). Thus, although we do not know the precise source of the DDT in our population, if populations living in areas with IRS spraying have maternal serum levels comparable to or higher than those in our study, then the associations we observed would still be relevant.

 

We do not currently have postnatal exposure information, but we attempted to account for postnatal exposure by using as a proxy the duration of breastfeeding, which is the primary source of postnatal exposure in children in the U.S. We also aimed to estimate postnatal exposure more precisely by examining the interaction between maternal levels of DDT/E and the duration of breastfeeding.

 

4. Measuring and interpreting outcome: The Bayley Scales of Infant Development II is a well-known assessment of infant development. We agree that any assessment of infants can have limited predictive validity, and we do not know the predictive validity of this test in this population. These issues necessitate both follow-up of these children into school age and similar studies in other populations. In the meantime, this study indicates a relationship within our population between maternal serum levels of DDT and neurodevelopment by age two years. Unless there was a systematic bias introduced in the assessment, i.e., all those with high exposure were assessed in a different manner, these associations merit consideration.

 

5. Measuring confounders and other variables: We considered for analyses many of the covariates mentioned by Dr. Goga, but did not consider any variables that were not considered in the literature to be related to the exposure or outcome or were possibly on the causal pathway.  We considered pertinent medical conditions, including those resulting from birth trauma, and the few children affected were excluded from the study either de facto (i.e. they were not assessed or valid scores could not be calculated) or in the data analysis. We have not yet measured postnatal exposure to neurotoxicants other than lead, which was low. To account for the associations observed, postnatal exposure to other neurotoxicants would need to be associated with prenatal DDT/E levels and unrelated to prenatal levels of the same chemicals, which we did consider in analyses.

 

The CES-D is a well-regarded tool to screen for maternal depression in epidemiologic investigations. Although available in Spanish, we agree it may not be a valid tool in an immigrant population. Nevertheless, the limitations of the instrument are consistent across this homogeneous population. We are not sure how the limitations of the CES-D would alter the conclusions of the present study on the associations of DDT and neurodevelopment.

 

6. Statistical analysis: We followed Dr. Goga’s suggestion to examine neurodevelopment by dichotomous exposure. Thus, we compared children with prenatal DDT/E exposure in the highest quartile to children whose exposure fell in the lowest quartile, controlling for the same covariates described in the paper (see Table 1 below). These new results are entirely consistent with the findings presented in the paper.

 

Specifically, as shown in Table 1, children in the highest quartile of prenatal exposure to p,p-DDT and p,p’-DDE had significantly lower mean PDI scores at 6 and 12 months (-3.3 to -5.8 points) and borderline lower mean PDI scores for p,p’-DDT at 24 months (-2.8 points) than children in the lowest quartile. Relative to the least exposed children, children in the highest quartile of both p,p’-DDT and o,p’-DDT exposure had significantly lower mean MDI scores at 12 months (-3.4 to -4.2 points), and children most highly exposed to both isomers of DDT and to DDE, had significantly lower mean MDI scores at 24 months (-4.0 to -5.1 points).

 

Regarding Dr. Goga’s other point about the source of exposure, as stated above, the serum DDT/E measures represent body burden. It is not possible to identify the source of the exposure, nor does it call into question the observed association. Furthermore, very little information is presently available on DDT exposure resulting from IRS, and there is a need for further exposure monitoring and research.

 

Table 1. Mean differences (95% CI) for points on the Bayley Psychomotor Development Index (PDI) and Mental Development Index (MDI) for highest versus lowest quartile of serum levels of p,p-DDT, o,p’-DDT, and p,p’-DDE in  CHAMACOS cohort.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

                                                 Mean difference (95% CI)

                           6 mo.                            12 mo.                     24 mo.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

PDI

   p,p'-DDT   -3.6 (-7.0, -0.3)**    -5.8 (-10.3, -1.2)**     -2.8 (-6.2, 0.6)*

   o,p'-DDT   -1.6 (-4.9,  1.7)        -2.9 ( -7.5,   1.8)          -2.1 (-5.6, 1.4) 

   p,p'-DDE   -3.3 (-6.3, -0.3)**    -4.4 ( -8.7, -0.04)**     1.0 (-2.3, 4.3) 

 

MDI

   p,p'-DDT    0.3 (-1.8,  2.4)       -3.4 (-6.5, -0.3)**       -5.1 (-9.0, -1.2)**

   o,p'-DDT   -0.1 (-2.3,  2.0)       -4.2 (-7.3, -1.1)***     -4.0 (-7.9, -0.1)**

   p,p'-DDE    0.3 (-1.7,  2.3)       -1.6 (-4.7,  1.4)            -4.9 (-8.6, -1.1)**

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

Models control for the same covariates summarized in Table 3 of original paper.

Children in middle quartiles of exposure were not included in these models.

*  p<0.10    

** p<0.05   

*** p<0.01

 

 

7. Other issues of concern: As stated in the paper [1], mean Bayley PDI scores at 6, 12, and 24 months were 96.4, 106.7, and 97.8, respectively; mean MDI scores were 95.4, 100.9, and 86.0.With the single exception of the 24-month MDI, these were all close to the expected mean score of 100, which would seem to indicate that using the age-standardized scores is not entirely unwarranted. If a child performed more than two standard deviations below the norm, the child’s guardian was informed, the child was referred to his or her pediatrician for further assessment, and study staff spoke to the pediatrician. Such assessments were excluded from these analyses since they were outliers.

 

The assessments were done for research, not clinical purposes, and the parents and clinicians were informed of this. We considered them inappropriate for clinical purposes, because we translated the instrument to Spanish (yet made no other modifications to the instrument), and although the psychometricians performing the assessments were trained extensively and were clinically supervised, they did not have graduate degrees. Given the paucity of bilingual psychologists in this community, we believed it was paramount to have assessments completed by bilingual bicultural members with experience with children from their community. Thus, these assessments were purely for research purposes to enable comparison of neurodevelopment within this population. While it is important to acknowledge the shortcomings of this instrument and administration, the relevant issue here is whether the methods of administration would alter the association of DDT and neurodevelopment in this population. Assessors were blind to DDT levels and exposure-related factors, thus there is no reason to believe that they would have been systematically biased in their assessments based on children’s exposures.

 

In summary, we agree that more data are needed on IRS exposure, that the children in the present cohort should be followed to determine the persistence of the observed associations and the contribution of breastfeeding, and that other studies should be conducted to examine these associations within other populations. In the meantime, we believe that it is for policy makers to weigh the benefits and risks of DDT use using all the data available.

 

Thank you.

 

 

REFERENCES

 

1. Eskenazi B, Marks AR, Bradman A, et al. In utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethylene (DDE) and neurodevelopment among young Mexican American children. Pediatrics 2006;118(1):233-41.

 

2. Bradman A, Schwartz JM, Fenster L, Barr D, Holland NT, Eskenazi B. Factors predicting organochlorine pesticide levels in pregnant women living in the Salinas Valley, California. JESEE 2006;In Press.

 

3. U.S. DHHS. Toxicological profile for DDT, DDE, and DDD. Atlanta, GA: U.S. Dept. of Health and Human Services Public Health Service, Agency for Toxic Substances and Disease Registry; 2002.

 

4. Bouwman H, Sereda B, Meinhardt HM. Simultaneous presence of DDT and pyrethroid residues in human breast milk from a malaria endemic area in South Africa. Environ Pollut 2006.

 

5. Waliszewski SM, Aguirre AA, Infanzon RM, Siliceo J. Persistent organochlorine pesticide levels in maternal blood serum, colostrum, and mature milk. Bull Environ Contam Toxicol 2002;68(3):324-31.

 

Conflict of Interest:

None declared